These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 17642195)

  • 1. [Invasive giant pituitary adenomas].
    Matsko DE; Vogel G; Ulitin AIu; Oliushin VE; Moes G; Pergamenshchikov AA; Burnin KS; Safarov BI; Markova NV
    Arkh Patol; 2007; 69(2):46-50. PubMed ID: 17642195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical tumor growth and comparison with proliferation markers in non-functioning (inactive) pituitary adenomas.
    Saeger W; Lüdecke B; Lüdecke DK
    Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):80-5. PubMed ID: 18072009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic correlates of giant pituitary adenomas.
    Chacko G; Chacko AG; Lombardero M; Mani S; Seshadri MS; Kovacs K; Scheithauer BW
    J Clin Neurosci; 2009 May; 16(5):660-5. PubMed ID: 19285407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between MRI invasive features and expression of EMMPRIN, galectin-3, and microvessel density in pituitary adenoma.
    Zhang Y; He N; Zhou J; Chen Y
    Clin Imaging; 2011; 35(3):165-73. PubMed ID: 21513851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pituitary adenomas: relationship between invasiveness and proliferative cell nuclear index].
    Tella Junior OI; Herculano MA; Delcelo R
    Arq Neuropsiquiatr; 2000 Dec; 58(4):1055-63. PubMed ID: 11105073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of pituitary tumor transforming gene, endostatin, and basic fibroblast growth factor mRNAs in invasive pituitary adenomas].
    Chen L; Liu YS; Wang LS; Yin HG; Hou QT; Liu ZX; Chen LH; Ling F
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 29(6):651-3, 666. PubMed ID: 16114549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between clinical, endocrinologic and nuclear magnetic resonance findings in women with suspected pituitary adenomas.
    Karande VC; Gole D; Kuhn JP; Crickard K
    J Reprod Med; 1990 May; 35(5):496-8. PubMed ID: 2112605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and structure of interleukin 4 receptor (IL-4R) complex in human invasive pituitary adenomas.
    Chen L; Liu Y; Hou Y; Kato Y; Sano H; Kanno T
    Neurosci Lett; 2007 Apr; 417(1):30-5. PubMed ID: 17398005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of Ki-67 labeling index in pituitary adenomas using MIB-1 monoclonal antibody.
    Lath R; Chacko G; Chandy MJ
    Neurol India; 2001 Jun; 49(2):144-7. PubMed ID: 11447433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyrotropin-secreting pituitary tumours: significance of "atypical adenomas" in a series of 10 patients and association with Hashimoto thyroiditis as a cause of delay in diagnosis.
    Marucci G; Faustini-Fustini M; Righi A; Pasquini E; Frank G; Agati R; Foschini MP
    J Clin Pathol; 2009 May; 62(5):455-9. PubMed ID: 19098060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic relevance of intracytoplasmic cytokeratin pattern, hormone expression profile, and cell proliferation in pituitary adenomas of akromegalic patients.
    Mazal PR; Czech T; Sedivy R; Aichholzer M; Wanschitz J; Klupp N; Budka H
    Clin Neuropathol; 2001; 20(4):163-71. PubMed ID: 11495005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrous bodies are associated with lower GH production and decreased expression of E-cadherin in GH-producing pituitary adenomas.
    Nishioka H; Haraoka J; Akada K
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):768-72. PubMed ID: 14974920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasiveness of pituitary adenomas.
    Sautner D; Saeger W
    Pathol Res Pract; 1991 Jun; 187(5):632-6. PubMed ID: 1923959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pituitary adenomas: value of MR imaging].
    Bonneville JF
    J Radiol; 2000 Sep; 81(9):939-42. PubMed ID: 10992090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nonfunctional or nonsecreting hypophyseal adenomas. Review of clinical, biological, neuroradiological, developmental and immunohistochemical characteristics. Apropos of 40 cases].
    Turpin G; Kujas M; Lam X; Heshmati HM; De Gennes JL
    Ann Med Interne (Paris); 1983; 134(6):520-4. PubMed ID: 6651074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osseous metaplasia in a growth hormone-secreting pituitary adenoma.
    Roncaroli F; Fioravanti A; Marliani AF; Calbucci F
    Clin Neuropathol; 1999; 18(4):205-7. PubMed ID: 10442463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New modalities in treating pituitary adenomas.
    Jackson I; Hennessey JV
    Med Health R I; 1996 Jun; 79(6):224-8. PubMed ID: 8797319
    [No Abstract]   [Full Text] [Related]  

  • 18. Spherical amyloid deposition in a prolactin-producing pituitary adenoma.
    Gul S; Bahadir B; Dusak A; Kalayci M; Edebali N; Acikgoz B
    Neuropathology; 2009 Feb; 29(1):81-4. PubMed ID: 18498287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pituitary adenomas: neurosurgical treatment].
    Wolfsberger S; Czech T; Knosp E
    Wien Klin Wochenschr; 2003; 115 Suppl 2():28-32. PubMed ID: 15518143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pituitary adenoma and concomitant Rathke's cleft cyst.
    Noh SJ; Ahn JY; Lee KS; Kim SH
    Acta Neurochir (Wien); 2007 Dec; 149(12):1223-8. PubMed ID: 17914599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.